Compare AbbVie Inc (ABBV) vs iShares Semiconductor ETF (SOXX) Price & Performance

AbbVie IncTrade

iShares Semiconductor ETFTrade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs iShares Semiconductor ETF — how do they compare? AbbVie Inc trades at $249.78 (market cap $441.94B), while iShares Semiconductor ETF trades at $545.11. The key difference: AbbVie Inc pays a 2.77% dividend while iShares Semiconductor ETF pays none. Which is the better fit depends on your goals.

	ABBV	SOXX
Market Cap	$441.94B	—
Sector	Health	Sector/Thematic
52-Week High	$263.58	$655.01
52-Week Low	$197.38	$241.68
Enterprise Value	$506.19B	—
Dividend Yield	2.77%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.

Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.

iShares Semiconductor ETF

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABBV

Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 23 hours agoNeutral Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 2 days agoNeutral Healthcare sector leads S&P 500 gains over 3 months with key pharma stocks showing strong innovation and income potential.24/7 Wall Street · 2 days agoBullish View details →

SOXX

Aura AI Photonics ETF launches, targeting AI data center optical tech amid hyperscaler spending watch.24/7 Wall Street · 13 hours agoNeutral iShares Semiconductor ETF outperforms VanEck's SMH by 20% in 2026 due to different weighting strategies.24/7 Wall Street · 3 days agoBullish S&P 500 hits record highs with options volume surging and VIX at January lows, signaling strong market confidence.CNBC · 4 days agoBullish View details →

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

About iShares Semiconductor ETF

SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.